OncoCyte: Q1 Earnings Snapshot

Published: 2025-05-12 16:37:15 ET OCX

Published on 05/12/2025 at 16:37

IRVINE, Calif. (AP) — IRVINE, Calif. (AP) — OncoCyte Corp. (OCX) on Monday reported a loss of $6.7 million in its first quarter.

The Irvine, California-based company said it had a loss of 26 cents per share.

The cancer diagnostic test developer posted revenue of $2.1 million in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OCX at https://www.zacks.com/ap/OCX

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News